Conference season and this week's health tech news
Seven meetings from the Twin Cities Foot & Ankle Conference to ACFAS Orlando, plus the week’s health tech news on AI liability, HTI-5 and compounded peptides, and who raised money.
Every issue of The Footnote, newest first. Each one keeps its own permanent link.
Seven meetings from the Twin Cities Foot & Ankle Conference to ACFAS Orlando, plus the week’s health tech news on AI liability, HTI-5 and compounded peptides, and who raised money.
Off the foot: mechanistic interpretability and neuralese, translated for clinicians, and why AI's reasoning is getting harder to read.
The innovation moving podiatry forward is mostly not AI: what it takes to bring an idea to market, CMS's 2027 proposals on wound imaging, skin substitutes and remote monitoring, and what weight-bearing CT and MIS bunion surgery really cost.
How The Footnote is made: an AI agent researches and drafts, a physician verifies every line, why that beats the link-stack trade newsletter, and what it says about the AI-fluent podiatrist.
Why podiatric medicine and surgery is a specialty of medicine: the training path, the federal law that already says physician, and the words DPMs should use to describe themselves.
For podiatry residents: choosing where to live and a practice model, health system vs. podiatry group vs. orthopedic practice, eight sourced job openings, and why AI fluency sets a candidate apart.
What a $120K department chair posting and a fax-only associate ad say about how podiatry recruits, a remembrance of Lowell Scott Weil Sr., DPM, and the Modifier 25 countdown.
What podiatrists need to know about AI: ambient scribe evidence, automation bias, disclosure laws, E/M coding risk, WISeR prior authorization and foot and ankle AI.
The joint AOFAS/IFFAS meeting, the proposed Modifier 25 cut, GLP-1 use and ankle fracture healing, and one-year MIS versus open Lapidus outcomes.
The podiatrists worth following on LinkedIn, ranked on public follower counts where they exist and verifiable signal where they don't.
Surgical research, policy and practice news for podiatry, each with the line on why it matters. One email a week. Unsubscribe anytime.
Subscribe free on Substack